P-13（​13therapeutics）

N/A

Report date: 2023/01/04 20:07:40

Base Information

Drug NameP-13（​13therapeutics）
Drug Alias NameP-13（​13therapeutics）
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionToll like receptor 4 antagonistsToll like receptor 2 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 4Toll like receptor 2Toll like receptor 9
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies​13therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies​13therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A